|

Combination 1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Pfizer1

Indications

  • Metastatic/Advanced Renal Cell Carcinoma1
  • Metastatic Renal Cell Cancer1
  • Carcinoma, Renal Cell, Advanced1
  • Advanced or Metastatic Renal Cell Carcinoma1
  • Carcinoma, Renal Cell Metastasis1

Springdale, Arkansas1 trial

A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Highlands Oncology Group

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.